The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Sustained action is needed now if we are to capitalise on the opportunity to eliminate viral hepatitis by 2030.
Epidemics of HIV and HPV are inherently interconnected – and when they meet in the context of weak health systems, their effects are amplifed.
Getting on top of the tuberculosis epidemic requires renewed attention, and bringing HIV out of isolation.
Opportunities to increase access to the hepatitis C cure exist – but strong political will is needed and many countries are failing to benefit from cheaper generics.
Despite the huge human and economic toll, research into hepatitis B remains drastically underfunded, and was recently alikened to a neglected tropical disease. But hope for a cure is growing.
In the run up to World Tuberculosis (TB) Day (March 24), the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization reveal the region is off- target to end TB by 2030.
As progress continues to fall short of the fast approaching 2030 targets, the World Health Organisation (WHO) calls for accelerated, multi-sectoral action against tuberculosis – the leading killer of people living with HIV.
Progress in halting TB – the world’s leading infectious disease killer – is plagued by a lack of political will and inequalities in healthcare access
Sitting in her small flat that she once shared with friends in Zimbabwe's capital Harare, Hope* (27), a sex worker chronicles life from her first diagnosis with tuberculosis (TB) and later HIV.
